You do know that SI himself holds close to 70 million shares and is by far the largest individual share holder in the company.
Now common sense would tell us SI more than anyone else want 'shareholder' wealth to increase by kicking goals and increasing share price.
FDA rejection is just a short term blip.
Very positive announcement.
Norvartis is one of the largest pharmaceutical company in the world and by they wouldn't be signing deals with MSB if they did not believe in the product.
- Forums
- ASX - By Stock
- MSB
- Ann: Novartis and Mesoblast Remestemcel-L Collaboration
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-305
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B |
Open | High | Low | Value | Volume |
$1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29972 | $1.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 2008 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29972 | 1.305 |
4 | 15000 | 1.300 |
1 | 772 | 1.295 |
6 | 63160 | 1.290 |
2 | 73667 | 1.285 |
Price($) | Vol. | No. |
---|---|---|
1.315 | 12924 | 1 |
1.320 | 14413 | 3 |
1.330 | 7511 | 1 |
1.350 | 5000 | 2 |
1.355 | 30300 | 1 |
Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |